SCHEMBL9257437

SCHEMBL9257437

O=C(Cc1c[nH]c2ccccc12)C1CSC(c2cccnc2)N1

nearest known ligand 0.70

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.57
▸ ALDH1A1 P00352 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4359626 0.82 — —
SCHEMBL9260138 0.82 — —
SCHEMBL9269994 0.80 HTR6 (0.45) KDM4EALDH1A1
Hydrochloric Acid SCHEMBL9261619 0.79 HTR6 (0.46) KDM4EALDH1A1
SCHEMBL9257440 0.76 MEN1 (0.44) KDM4EALDH1A1
SCHEMBL9268994 0.74 KDM4E (0.58) KDM4EALDH1A1
SCHEMBL9250734 0.73 ALDH1A1 (1.00) KDM4EALDH1A1
SCHEMBL8870395 0.73 ALDH1A1 (1.00) KDM4EALDH1A1
SCHEMBL3825291 0.73 ALDH1A1 (1.00) KDM4EALDH1A1
SCHEMBL3825287 0.73 ALDH1A1 (1.00) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5382670-A Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1995-01-17 — — US disclosed
EP-0574494-A4 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LAB (US) 1994-07-06 — — EP disclosed
EP-0574494-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1993-12-22 — — EP disclosed
WO-1992014732-A1 INDOLES USEFUL AS PLATELET ACTIVATING FACTOR ANTAGONISTS ABBOTT LABORATORIES (US) 1992-09-03 — — WO disclosed
EP-0499987-A1 Platelet activating factor antagonists ABBOTT LABORATORIES (US) 1992-08-26 — — EP disclosed
US-5120749-A Treatment of anaphylactic shock, respiratory distress syndrome, acute inflammation, delayed cellulosr immunity, parturtition, fetal lung maturation, and cellular differentiation ABBOTT LABORATORIES (US) 1992-06-09 — — US disclosed
Send feedback